Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Study.
Bleibtreu A, Dortet L, Bonnin RA, Wyplosz B, Sacleux SC, Mihaila L, Dupont H, Junot H, Bunel V, Grall N, Razazi K, Duran C, Tattevin P, Dinh A, The Cefiderocol French Study Group OBO.
Bleibtreu A, et al. Among authors: bunel v.
Microorganisms. 2021 Jan 30;9(2):282. doi: 10.3390/microorganisms9020282.
Microorganisms. 2021.
PMID: 33573148
Free PMC article.